BSE Announcement

Ador Welding will hold a meeting of the Board of Directors of the Company on 29 April 2026.

Aeroflex Enterprises will hold a meeting of the Board of Directors of the Company on 29 April 2026.

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fingolimod Capsules, 0.5 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis).

Fingolimod is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in patients 10 years of age and older.

Fingolimod Capsules, 0.5 mg, have an estimated market size of US$ 145 million for twelve months ending December 2025 according to IQVIA.

APL Apollo Tubes will hold a meeting of the Board of Directors of the Company on 2 May 2026.

Aster DM Healthcare will hold a meeting of the Board of Directors of the Company on 30 April 2026.

Axis Bank announced that the Board of Directors of the Company at its meeting held on 25 April 2026, has recommended a Final Dividend of Rs.1 per share (i.e.50%), subject to the approval of the shareholders.

Aye Finance has allotted 4,20,784 equity shares under at a face value of Rs 2 each from Aye Finance Employees Welfare Trust to the eligible grantee upon exercise of options granted under existing ESOP 2016 of the Company.

Consequent to the aforementioned transfer, the paid up share capital of the Company shall stand remain same i.e. 24,67,84,266 equity shares at a face value of Rs 2 each aggregating to Rs 49,35,68,532

BCC Fuba India will hold a meeting of the Board of Directors of the Company on 29 April 2026.

BP Capital announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 25 April 2026.

Bhansali Engineering Polymers announced that the Board of Directors of the Company at its meeting held on 24 April 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.